Skip to main content
Year archive

ARS Pharmaceuticals, Inc. — 2021 filings

All 30 regulatory filings released by ARS Pharmaceuticals, Inc. (SPRY) in 2021, sourced directly from the official regulator.

30 Filings
2021 Period
2021 filings (30)
Filing Released Lang
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Director's Dealing
2021-12-15 English
10-Q
Interim / Quarterly Report Q3 2021
2021-11-10 English
8-K
Regulatory Filings
2021-11-10 English
FORM 4 SUBMISSION
Director's Dealing
2021-09-21 English
FORM 4 SUBMISSION
Director's Dealing
2021-09-21 English
FORM 4 SUBMISSION
Director's Dealing
2021-09-21 English
FORM 4 SUBMISSION
Director's Dealing
2021-09-21 English
FORM 4 SUBMISSION
Director's Dealing
2021-09-21 English
FORM 4 SUBMISSION
Director's Dealing
2021-09-21 English
8-K
Regulatory Filings
2021-09-16 English
8-K
Regulatory Filings
2021-09-13 English
10-Q
Interim / Quarterly Report Q2 2021
2021-08-12 English
8-K
Regulatory Filings
2021-08-12 English
8-K
Regulatory Filings
2021-07-02 English
8-K
Regulatory Filings
2021-06-09 English
10-Q
Interim / Quarterly Report Q1 2021
2021-05-13 English
8-K
Regulatory Filings
2021-05-13 English
DEFA14A
Regulatory Filings
2021-04-22 English
DEF 14A
Proxy Solicitation & Information Statement
2021-04-22 English
S-8
Registration Form
2021-03-29 English
FORM 10-K
Annual Report FY 2020
2021-03-29 English
8-K
Regulatory Filings
2021-03-29 English
FORM 4 SUBMISSION
Director's Dealing
2021-03-16 English
FORM 3 SUBMISSION
Director's Dealing
2021-03-16 English
8-K
Regulatory Filings
2021-03-15 English
SCHEDULE 13G
Major Shareholding Notification
2021-02-16 English
SC 13G
Major Shareholding Notification
2021-02-16 English
Major Shareholding Notification 2021
Major Shareholding Notification
2021-02-10 English
Major Shareholding Notification 2021
Major Shareholding Notification
2021-02-08 English
Major Shareholding Notification 2021
Major Shareholding Notification
2021-01-04 English